XML 105 R86.htm IDEA: XBRL DOCUMENT v3.25.0.1
Earnings Per Share - Narrative (Details) - $ / shares
shares in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jul. 26, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common stock, par value (in dollars per share) $ 0.01 $ 0.01    
Weighted average shares outstanding - basic (in shares) 227,525 225,209 190,463  
Stock Purchase Contracts        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares issuable upon conversion (in shares) 34,800      
The Warrant        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares authorized to be purchased 11,100      
Ventas, Inc | The Warrant        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares authorized to be purchased       16,300
Common stock, par value (in dollars per share)       $ 0.01
Share price (in usd per share)       $ 3.00
Issuance of common stock and tangible equity units, net of issuance costs (in shares) 2,900      
Class of warrant or right, exercised (in shares) 5,200      
2026 Notes at initial conversion rate        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares issuable upon conversion (in shares) 3,900      
Number of additional shares issuable upon conversion (in shares) 1,000      
2029 Notes at initial conversion rate        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares issuable upon conversion (in shares) 55,000      
Number of additional shares issuable upon conversion (in shares) 13,900